Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2017/0232111 PEGYLATION METHOD
The present invention relates to a method for PEGylating interferon beta.
2017/0232110 CONJUGATE FOR TREATING MALARIA
A peptide-polymer conjugate is provided for use in treating malaria infections, and in particular terminal or drug resistant malaria infections. The conjugate...
2017/0232109 PROTEIN/OLIGONUCLEOTIDE CORE-SHELL NANOPARTICLE THERAPEUTICS
The present disclosure is directed to core-shell nanoparticles, compositions comprising core-shell nanoparticles, and methods of their use.
2017/0232108 MATERIALS AND METHODS RELATING TO LINKERS FOR USE IN PROTEIN DRUG CONJUGATES
The present invention relates to protein drug conjugates, methods of manufacturing the same and their use in therapy. In particular, the present invention...
2017/0232107 PHARMACEUTICAL COMPOSITION COMPRISING ANTIEMETIC COMPOUNDS AND POLYORTHOESTER
The present disclosure provides for sustained release pharmaceutical formulations which can deliver both a 5-hydroxytryptamine 3 (5HT3) receptor antagonist and...
2017/0232106 FORMULATION AND METHOD FOR PRODUCING SAME
An object is to provide a formulation that includes a particle containing an active ingredient and a surfactant, and a base, and is more excellent in storage...
2017/0232105 METHOD AND COMPOSITIONS FOR SOLUBILIZING NON-POLAR CONSTITUENTS
A method for solubilizing non-polar target compounds into a carrier liquid is described. A carrier oil, such as a MCT, or a mixture of MCTs, may be used to...
2017/0232104 STABLE IGG4 BASED BINDING AGENT FORMULATIONS
The present invention provides stable pharmaceutical antibody formulations, including liquid drug product formulations and lyophilized drug product...
2017/0232103 EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS
The invention encompasses formulations and methods for the production thereof that permit the delivery of concentrated protein solutions. The inventive methods...
2017/0232102 HEMATOLOGIC CANCER TREATMENTS
Disclosed herein are improved compositions and methods involved in treating hematologic cancers, i.e., cancers that begin in blood-forming tissue, such as the...
2017/0232101 Polyvalent Pneumococcal Polysaccharide-Protein Conjugate Composition
Provided is an immunogenic composition comprising 15 different polysaccharide-protein conjugates. Each of the conjugates comprises a capsular polysaccharide...
2017/0232100 Vaccines Having an Antigen and Interleukin-21 As An Adjuvant
Disclosed herein is a vaccine comprising an antigen and IL-21. Also disclosed herein are methods for increasing an immune response in a subject. The methods...
2017/0232099 THERAPY-ENHANCING GLUCAN
This invention provides a composition comprising an effective amount of glucan capable of enhancing efficacy of antibodies. This invention further provides the...
2017/0232098 RECOMBINANT MUMPS VIRUS VACCINE
The present invention provides the complete genomic sequence of the epidemic mumps virus (MuV) strain MuV.sup.Iowa/US/06. Further, a reverse genetics system...
2017/0232097 Live Attenuated Viral Vaccine Created by Self-Attenuation With Species-Specific Artificial MicroRNA
The present invention includes a live attenuated virus and methods of making the same comprising an isolated virus comprising a viral genome that expresses one...
2017/0232096 VACCINE IN THE FORM OF A RECOMBINANT SERO TYPE 9 AVIAN ADENOVIRUS VECTOR
A recombinant vaccine comprising a serotype 9 fowl adenovirus vector (FAdV-9) having at least one exogenous nucleotide sequence inserted encoding at least one...
2017/0232095 FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
Recombinant influenza virus proteins, including influenza capsomers, subviral particles, virus-like particles (VLP), VLP complexes, and/or any portions of...
2017/0232094 PORCINE CIRCOVIRUS TYPE 2 (PCV2) SUBUNIT VACCINE
Vaccination methods to control PCV2 infection with different PCV2 subtypes are disclosed. Specifically, a PCV2 subtype b (PCV2b) ORF2 proteins or immunogenic...
2017/0232093 MODIFIED HOST CELLS AND HYBRID OLIGOSACCHARIDES FOR USE IN BIOCONJUGATE PRODUCTION
Provided herein are host cells capable of producing hybrid oligosaccharides and polysaccharides, wherein said hybrid oligosaccharides and polysaccharides do...
2017/0232092 METHODS AND COMPOSITIONS FOR T CELL GENERATION AND USES THEREOF
Among the various aspects of the present disclosure is the provision of a method of treating an inflammatory bowel disease. Another aspect provides the...
2017/0232091 NOVEL ANTIGEN FOR USE IN MALARIA
The present invention provides polypeptides useful as antigens expressed at the pre-erythrocytic stage of the malaria parasite. The antigens can be utilized to...
2017/0232090 MULTI-INDICATION MRNA CANCER IMMUNOTHERAPY
Synthetic bacterial messenger RNA can be used to prepare autologous, allogenic or direct nucleic acid cancer vaccines. Cancer cells are transfected either in...
2017/0232089 CANCER VACCINE COMPOSITION
A cancer vaccine composition for human leukocyte antigen (HLA)-A*0206-positive persons, comprising a protein product of the tumor suppressor gene WT1 or a...
2017/0232088 TELOMERASE POLYPEPTIDE VACCINE FOR TREATING CANCER
A polypeptide comprising the sequence of SEQ. ID NO. 2, 3, 4, 7 or 8. The polypeptide may have the sequence of an immunogenic fragment thereof comprising at...
2017/0232087 TELOMERASE POLYPEPTIDE VACCINE FOR TREATING CANCER
A polypeptide comprising the sequence of SEQ. ID NO. 2, 3, 4, 7 or 8. The polypeptide may have the sequence of an immunogenic fragment thereof comprising at...
2017/0232086 CRYOPRESERVATION OF APOPTOTIC CANCER CELLS FOR USE IN IMMUNOTHERAPY AGAINST CANCER
Described herein is a reliable method for preparing a potent vaccine useful for immunotherapy comprising the step of cryopreserving a population of cells...
2017/0232085 COMPANION ANIMAL TREATMENTS
The invention relates to minimising the progression of cancer in a companion animal using P2X.sub.7 immunotherapy.
2017/0232084 IMMUNE MODULATION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
The invention provides methods for treating age-related macular degeneration by administering (i) peptide compositions, (ii) regulatory T-cells from the...
2017/0232083 METHODS OF DIAGNOSIS AND TREATMENT OF CELIAC DISEASE IN CHILDREN
Provided herein are compositions and methods for treating and/or identifying children having or suspected of having Celiac disease.
2017/0232082 SYNTHETIC ACTIVE PEPTIDE FRAGMENTS
The present invention relates to peptide fragments which have one or more shared and/or similar amino acid sequences to amino acid sequences of specific...
2017/0232081 METHODS FOR TREATMENT OF AND PROPHYLAXIS AGAINST INFLAMMATORY DISORDERS
An isolated and purified peptide, neonatal NET-inhibitory Factor (nNIF), is disclosed. Methods for treatment of and prophylaxis against inflammatory disorders...
2017/0232080 Treatment of Migraine Headaches with Presynaptic Neurotoxin
The present invention provides a method for treating a patient for migraine headache, including symptoms associated with migraine head ache, such as migraine...
2017/0232079 METHOD OF MANUFACTURING PROTHROMBIN COMPLEX CONCENTRATE FROM FRACTION III AND NON-PROTHROMBIN COMPLEX...
The present subject matter is directed to a method of manufacturing and purifying an intravenous injection of prothrombin complex concentration (PCC) from...
2017/0232078 METHOD FOR PROPHYLAXIS AND/OR TREATMENT OF ERBB1 POSITIVE CANCERS
Provided are compositions and methods for prophylaxis and/or therapy of ErbB1-positive cancer. The compositions include pharmaceutical preparations that...
2017/0232077 COMPOSITIONS AND METHODS FOR TREATING GLUTEN INTOLERANCE AND DISORDERS ARISING THEREFROM
The invention described herein relates to methods and compositions for treatment of one or more symptoms of gluten intolerance and related conditions (e.g.,...
2017/0232076 MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
A targeted therapeutic including a lysosomal enzyme and a lysosomal targeting moiety that is a peptide containing at least one N-linked glycosylation site....
2017/0232074 ENHANCEMENT OF SKELETAL MUSCLE STEM CELL ENGRAFTMENT BY DUAL DELIVERY OF VEGF AND IGF-1
An improved device and method for extended repair and regeneration of muscle tissue. An exemplary device comprises (a) a scaffold comprising an ECM component;...
2017/0232073 ELEVATED INTRACRANIAL PRESSURE TREATMENT
Provided is an incretin, or analogue thereof, an incretin receptor agonist, an incretin enhancer, or any combination thereof, for use in a method of reducing...
2017/0232072 TREATING CARDIOVASCULAR OR RENAL DISEASES
This document provides methods and materials for treating cardiovascular and/or renal diseases. For example, AAV9 vectors designed to express natriuretic...
2017/0232071 Interferon Therapy
Interferon therapy is improved by concomitant administration of an agent which minimizes the ability of interferon to up-regulate expression of Programmed Cell...
2017/0232070 Combination Methods for Immunotherapy
The present invention includes a method of treating prostate cancer in a human subject in need thereof, comprising administering to the subject an effective...
2017/0232069 COMPOSITIONS FOR THE TREATMENT OF PERITONITIS
The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and antimicrobial agents for the treatment, pre-emptive...
2017/0232068 Methods and Compositions of Neuregulins for Preventing, Treating or Delaying Preserved Ejection Fraction...
Disclosed are the use of neuregulin proteins in preparing a medicine for preventing, treating or delaying preserved ejection fraction cardiac failure in...
2017/0232067 PHARMACEUTICAL COMPOSITIONS COMPRISING PEPTIDE VARIANTS AND METHODS OF USE THEREOF
Provided herein are pharmaceutical compositions, formulations and dosage forms comprising variants of fibroblast growth factor 19 (FGF19) proteins and peptide...
2017/0232066 TISSUE PROTECTIVE PEPTIDES AND PEPTIDE ANALOGS FOR PREVENTING AND TREATING DISEASES AND DISORDERS ASSOCIATED...
The present invention provides peptides and peptide analogs that have tissue protective activities while having little or no potentially undesirable...
2017/0232065 PROMOTING EPITHELIAL REGENERATION USING HEPARIN BINDING EPIDERMAL GROWTH FACTOR LIKE GROWTH FACTOR
Compositions and methods for promoting epithelial tissue regeneration to treat an oral or oropharyngeal wound, e.g., after tonsillectomy are disclosed. In...
2017/0232064 FORMULATIONS FOR HISTATIN THERAPEUTICS
Histatins may be used for skin wound healing in humans and other animals. For example, histatins could be included in gels, ointments, creams, tissue glues,...
2017/0232063 USES OF CASEIN COMPOSITIONS
Casein compositions for increasing the rate of gastric emptying following ingestion of the composition, increasing the digestibility of a protein composition,...
2017/0232062 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER...
This invention relates to a protein C1ORF32 and its variants and fragments and fusion proteins thereof, and methods of use thereof for immunotherapy, and drug...
2017/0232061 Soluble Mediator
The present disclosure relates to a soluble CD52 glycoprotein and its use in treating diseases regulated by effector T-cells, for example autoimmune diseases...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.